COMPANY WORKBOOK · BMY
Bristol-Myers Squibb Company
Healthcare & Life Sciences · N/A
$62.62-0.70%
59/100
INTERACTIVE PRICE CHART
Trend and moving averages
RELATIVE PERFORMANCE
BMY versus SPY and SMH
Indexed to 100
Cross-sectional ranking
Scores are percentile-ranked against the current Young Bull universe and stored by date in PostgreSQL.
Healthcare & Life Sciences
This company is available as a market-data workbook. Young Bull has not added a manual investment thesis for it yet.
MODEL READ
Overall score: 59.4. Last ranked 2026-09-22.
QUARTERLY FUNDAMENTALS
Revenue and earnings power
TRAILING P/E13.89
PRICE / SALES2.619
EV / EBITDA9.68
BOOK VALUE10.93
GROSS MARGINN/A
PROFIT MARGIN18.9%
RETURN ON EQUITY46.6%
FREE CASH FLOWN/A
What it does
Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City. Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders.
PRIMARY SOURCES